| Record ID | marc_loc_updates/v37.i06.records.utf8:12200728:1429 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v37.i06.records.utf8:12200728:1429?format=raw |
LEADER: 01429nam a22003738a 4500
001 2009003127
003 DLC
005 20090203103703.0
008 090127s2009 flu b 001 0 eng
010 $a 2009003127
020 $a9781420070378 (hardcover : alk. paper)
035 $a(DNLM)101494575
040 $aDNLM/DLC$cDLC
042 $apcc
050 00 $aRM301.27$b.H47 2009
060 10 $aQV 771$bH572d 2009
082 00 $a615/.19$222
100 1 $aHerson, Jay.
245 10 $aData and safety monitoring committees in clinical trials /$cJay Herson.
260 $aBoca Raton :$bChapman & Hall/CRC/Taylor & Francis,$c2009.
263 $a0903
300 $ap. ;$ccm.
490 1 $aChapman & Hall/CRC biostatistics series ;$v30
504 $aIncludes bibliographical references and index.
505 0 $aOrganization of a safety monitoring program -- Meetings -- Clinical issues -- Statistical issues -- Bias and pitfalls -- Data monitoring committee decisions -- Emerging issues.
650 0 $aDrugs$xTesting$xEvaluation.
650 0 $aDrugs$xTesting$xStatistical methods$xEvaluation.
650 12 $aClinical Trials Data Monitoring Committees$xorganization & administration.
650 12 $aClinical Trials as Topic$xstandards.
650 22 $aData Collection.
650 22 $aDrug Industry$xstandards.
650 22 $aResearch Design.
650 22 $aSafety Management.
830 0 $aChapman & Hall/CRC biostatistics series ;$v30.